The vehicle, Avista Healthcare Partners CV II, provides liquidity to existing LPs while allowing continued participation in GCM's growth trajectory. The fund includes substantial unfunded capital earmarked for strategic acquisitions and future investments. Avista originally acquired GCM in 2019 and has since driven a transformation of the business, focusing on manufacturing excellence, technological upgrades, and commercial expansion. Under Avista's ownership, GCM has more than doubled its revenue, becoming a key supplier to OEMs in robotic surgery and other high-growth medtech segments. 'We are pleased to provide our investors with the choice of liquidity or continued participation in GCM's strong growth path,' said Rob Girardi, Partner at Avista. 'This marks an exciting new chapter for GCM and underscores our commitment to value creation across the healthcare sector.' Subscribe to our Newsletter to increase your edge. Don't worry about the news anymore, through our newsletter...
learn more
